DexCom (DXCM)
(Delayed Data from NSDQ)
$66.73 USD
-1.93 (-2.81%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $66.50 -0.23 (-0.34%) 5:30 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 29% (72 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.66 | 9.99 |
Current Quarter Estimate | 0.44 | 4.85 | 61.00 |
Year Ago Quarter Estimate | 0.50 | 3.52 | 54.84 |
Next Quarter Estimate | 0.51 | 5.65 | 63.00 |
Next Year Estimate | 2.01 | 24.56 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 11.18 | 12.50 | 15.67 |
Next Year | 18.93 | 20.50 | 11.34 |
Last 5 Years | 61.10 | 10.20 | 8.10 |
Next 5 Years | 19.10 | 13.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 39.23 | 7.07 |
Price/Book (MRQ) | 11.30 | 2.40 |
Price/Cash Flow (MRFY) | 33.18 | 19.09 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 16.95% | -27.83% |
Return on Equity (TTM) | 31.41% | -23.39% |
Debt to Equity (MRQ) | 1.00 | 8.83 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.